## **Chapter 37. Biology Experiment**

Recommended Post: 【Biology】 [Table of Contents for Biology](https://jb243.github.io/pages/1457)

---

**1.** [Quantitative Experiment](#1-quantitative-experiment)

**2.** [Cell Experiment](#2-cell-experiment)

**3.** [Tissue Experiment](#3-tissue-experiment)

**4.** [Animal Experiment](#4-animal-experiment)

**5.** [Clinical Trial](#5-clinical-trial)

---

**a.** [Optical Microscope](https://jb243.github.io/pages/783)

**b.** [Transmission Electron Microscope](https://jb243.github.io/pages/782)

**c.** [Immune Analysis Method](https://jb243.github.io/pages/1461)

**d.** [Pharmacology](https://jb243.github.io/pages/2197)(PK/PD)

**e.** [Microbiology Experiment](https://jb243.github.io/pages/1487)

**f.** [Cell Culture Protocol](https://jb243.github.io/pages/1736)

**g.** [Types of Fluorescent Substances Used in Biological Experiments](https://jb243.github.io/pages/763)

**h.** [Abbreviations Related to Biology Experiments](https://jb243.github.io/pages/787)

---

<br>

## **1\. Quantitative Experiment**

⑴ **Method 1.** Centrifugation

> ① Cell Fractionation Method

<br>

<img width="640" height="221" alt="image" src="https://github.com/user-attachments/assets/31b50e51-e7fe-47db-87e2-ad42294640a0" />

**Figure 1.** Cell Fractionation Method

A represents nucleus, B represents chloroplasts, C represents mitochondria

<br>

>> ○ 1st Centrifugation (1,000g, 10 minutes): Nucleus precipitates

>> ○ 2nd Centrifugation (3,000g, 10 minutes): Chloroplasts precipitate

>> ○ 3rd Centrifugation (20,000g, 10 minutes): Mitochondria precipitate

>> ○ 4th Centrifugation (150,000g, 180 minutes): Vesicles precipitate

>> ○ Sedimentation Coefficient S

>>> ○ Svedberg unit

>>> ○ Sedimentation coefficient by sucrose gradient

>>> ○ Simple summation does not hold

> ② CsCl2 [Density Gradient Centrifugation](https://jb243.github.io/pages/1462): particles come to rest at their characteristic density.

> ③ Sucrose Concentration Gradient Centrifugation

>> ○ Principle: Direct movement. Lower partition has higher density

>> ○ Advantages: Actual collection can be done

⑵ **Method 2.** Absorption Quantification

> ① **Example 1.** Colorimetric lactate quantification: Measurement of lactate content

⑶ **Method 3.** Fluorescence Quantification

> ① Major Fluorescent Substances

>> ○ Alexa series: Has NHS moiety for amine coupling

>> ○ Di series: Lipophilic dye

>> ○ FITC: Coupled with amine

>> ○ GFP: Protein emitting green fluorescence upon UV exposure

>> ○ SITS: Fluorescent substance specifically labeling amino group

>> ○ Syto60: DNA dye

>> ○ SYTOX: Measures dead cell amount using green fluorescent substance binding to chromatin

>> ○ [Other Fluorescent Substances Used in Biological Experiments](https://jb243.github.io/pages/763)

> ② **ELISA** (enzyme linked immunosorbent assay)

>> ○ Definition: Method used for detecting and quantifying specific antibodies and antigens

>> ○ Direct ELISA: Constructs a structure like BSA - Target Molecule - 1st Antibody - 2nd Antibody to observe fluorescence

>>> ○ BSA: Improves resolution

>>> ○ 1st and 2nd antibodies should be from different animal species ( **∵** To enhance immune reaction sensitivity)

>> ○ Indirect ELISA: Constructs a structure like BSA - 1st Antibody - Target Molecule - 2nd Antibody to observe fluorescence

>>> ○ BSA: Improves resolution

>>> ○ 1st and 2nd antibodies should be from different animal species ( **∵** To enhance immune reaction sensitivity)

>> ○ Disadvantages

>>> ○ Not automated, labor-intensive

>>> ○ Expensive due to needing different antibodies for each target molecule

>>> ○ Dependent on fluorescence, so auto-fluorescence might occur

> ③ **FRET** (Förster/fluorescence resonance energy transfer)

>> ○ Purpose: Proximity assessment of two proteins

>> ○ Principle: Fluorescence resonance energy transfer

⑷ <b>Method 4.</b> Radiometric quantification

> ① Hydrogen (<sup>3</sup>H): nucleic acid quantification

>> ○ [<sup>3</sup>H]-dT (deoxythymidine): a compound used to radioactively label cellular DNA.

>>> ○ pulse–chase: apply radioactive labeling for a defined period, then stop labeling to observe subsequent changes.

>>> ○ pulse labeling: apply labeling continuously and monitor.

>> ○ [<sup>3</sup>H]-UDP: targets sites where transcription occurs.

> ② Carbon (<sup>16</sup>C): track glucose to diagnose cancer.

> ③ Fluorine (<sup>18</sup>F): FDG for PET–CT examinations.

> ④ Phosphorus (<sup>32</sup>P): DNA tracking

>> ○ α-<sup>32</sup>P in ATP: radioisotope attached at ATP's α position.

>>> ○ Track phosphate groups in phosphodiester bonds (the DNA/RNA backbone).

>>> ○ Check for the presence of nucleotides themselves.

>> ○ γ-<sup>32</sup>P in ATP: radioisotope attached at ATP's γ position.

>>> ○ Track phosphate groups in signal transduction.

>>> ○ Verify polymerization reactions.

> ⑤ Sulfur (<sup>35</sup>S): protein tracking.

> ⑥ Technetium (<sup>99m</sup>Tc): used in >70% of nuclear-medicine examinations.

> ⑦ Indium (<sup>111</sup>In): brain-tumor imaging.

> ⑧ Iodine (<sup>123</sup>I): thyroid-disease testing.

> ⑨ Iodine (<sup>124</sup>I): PET imaging.

> ⑩ Iodine (<sup>125</sup>I): in-vitro specimen assays; thyroid therapy.

> ⑪ Iodine (<sup>131</sup>I): treatment of thyroid tumors.

> ⑫ Thallium (<sup>201</sup>Tl): cardiac testing.

⑸ **Application 1.** [Protein Content Analysis Method](https://jb243.github.io/pages/481)

> ① Purpose: Measuring concentration of metabolites, receptor concentration, enzyme affinity

> ② Folin-Lowry method

>> ○ Principle: Folin reagent reacts with aromatic amino acids like tyrosine, phenylalanine, tryptophan

>> ○ Absorbance is measured by exploiting the blue color produced upon treatment with alkaline copper.

>> ○ Range: 20 ~ 400 μg/ml

>> ○ Disadvantage: Underestimates protein quantity if protein contains relatively fewer aromatic amino acids

> ③ Bradford method

>> ○ Principle: Coomassie Blue G-250 binds to proteins under acidic conditions causing absorbance change

>> ○ In dye-only condition, has 465 nm absorbance, while in protein + dye condition, has 595 nm absorbance

>> ○ Advantages: Not dependent on aromatic amino acid content

>> ○ Disadvantage: About 5 times more sensitive than Lowry method, so absorbance must be measured within 30 minutes

> ④ Biuret

>> ○ Principle: Binding of Cu2+ with NH groups in proteins

>> ○ Range: 1 ~ 20 mg/ml

>> ○ Disadvantage: Rough method

> ⑤ [BCA assay](https://jb243.github.io/pages/481)

> ⑥ UV 280 nm [spectrometer](https://jb243.github.io/pages/1404)

>> ○ Principle: Uses 280 nm absorbance of phenyl groups in Phe, Trp, Tyr as representative

>> ○ Disadvantage: Might have interference with DNA and about 10 times less sensitive than Lowry method

⑹ **Application 2.** Nucleic Acid Content Analysis Method

> ① Hoechst 33258 method

>> ○ Measure fluorescence arising from the interaction of Hoechst 33258 with DNA at 458 nm.

>> ○ Quantifiable down to 10 ng/mL, but requires intact double-stranded DNA (dsDNA).

> ② [DAPI](https://jb243.github.io/pages/77)(diamidino-2-phenylindole) method

>> ○ Measure fluorescence at 454 nm.

>> ○ Binds to AT-rich regions in DNA minor groove.

>> ○ Also used as an apoptosis marker.

> ③ UV absorbance at 260 nm

>> ○ <b>Data 1.</b>

>>> ○ OD 1.0 for dsDNA corresponds to 50 μg/mL.

>>> ○ OD 1.0 for ssDNA corresponds to 40 μg/mL.

>> ○ <b>Data 2.</b> Hyperchromic effect

>>> ○ Set dsDNA = 1.0 and express other nucleic acids relatively

>>> ○ ssDNA: 1.37

>>> ○ Fragmented nucleotides: 1.5

>> ○ Because proteins interfere, use purified DNA only.

> ④ RiboGreen assay

>> ○ Quantifies the RNA concentration in solution.

⑺ **Application 3.** [Immune Analysis Method](https://jb243.github.io/pages/1461): Immune precipitation, Radioimmune analysis,
Immunohistochemistry, 3D immunostaining, etc.

⑻ **Application 4.** Binding Assay: Method to measure affinity between target and targeting agent

> ① [Yeast Two Hybrid Assay](https://jb243.github.io/pages/77#:~:text=%E2%91%B4-,%EC%9D%B4%EC%A4%91%EC%9E%A1%EC%A2%85%EC%B2%B4%EA%B3%84,-%3A%20%EB%8B%A8%EB%B0%B1%EC%A7%88%20X%EC%99%80)

> ② Surface Plasmon Resonance

> ③ Isothermal Titration Calorimetry

> ④ Gel Chromatography

> ⑤ [NMR Spectroscopy](https://jb243.github.io/pages/1404#footnote_link_67_54)

> ⑥ X-ray Crystallography

> ⑦ Cryo-Electron Microscopy

> ⑧ [Radioligand Binding Assay](https://jb243.github.io/pages/378)

<br>

<br>

## **2\. Cell Experiment**

⑴ Microscope

> ① [Optical Microscope](https://jb243.github.io/pages/783)

> ② Scanning Electron Microscope (SEM): Surface structure observation

> ③ [Transmission Electron Microscope](https://jb243.github.io/pages/782) (TEM): Internal structure observation

> ④ [Scanning Tunneling Microscope](https://jb243.github.io/pages/1329) (STM): Surface structure observation

> ⑤ Atomic Force Microscope (AFM)

> ⑥ Dark-Field Microscope

> ⑦ Fluorescence Microscope

⑵ [Cell Culture](https://jb243.github.io/pages/1736)

> ① **Type 1.** Transwell-Based Model

>> ○ Migration

>> ○ Invasion

>> ○ Transendothelial Migration

> ② **Type 2.** Spheroid-Based Model

>> ○ Cell Suspension Culture

>> ○ Non-Adherent Surface

>> ○ Hanging Drop Technique

>> ○ Microfluidic Device

> ③ **Type 3.** Hybrid Model

>> ○ Embedded Ex Vivo Tumor Section

>> ○ 3D Invasion Model

>> ○ Avascular Microfluidic Model

> ④ **Type 4.** Tumor-Microvessel Model

>> ○ Predefined ECM Scaffold

>> ○ Microvessel Self-Assembly

⑶ Cell Counting

> ① Hemocytometer

>> ○ Originally used to count red and white blood cells

>> ○ [Cell Quantification Protocol using Hemocytometer](https://jb243.github.io/pages/446)

> ② Coulter Counter: Electronic Particle Counting

>> ○ 1<sup>st</sup>. Cells are sucked through narrow pores, causing a change in current flow

>> ○ 2<sup>nd</sup>. Change in current flow generates pulses

>> ○ 3<sup>rd</sup>. Machine counts pulses to calculate cell number

>> ○ Features: Can also do cell sizing, quantify ratio of living cells, aggregate cell quantification, not just cell counting

> ③ Stained Monolayer

>> ○ Fixing cells directly on multi-well plate or Terasaki plate and staining for counting

>> ○ Can be used when cell number is very low

> ④ Cell Weight

>> ○ Used occasionally with inaccuracies when cell numbers are very high

>> ○ **Example 1.** Murine Leukemia (e.g., L5178Y)

>>> ○ Diameter: 11-12 μm. Volume: 800 μm<sup>3</sup>

>>> ○ Cells/g × 10<sup>6</sup>: 1250 (calculated), 1000 (measured)

>> ○ **Example 2.** Hela

>>> ○ Diameter: 14-16 μm. Volume: 1200 μm<sup>3</sup>

>>> ○ Cells/g × 10<sup>6</sup>: 800 (calculated), 250 (measured)

>> ○ **Example 3.** Human Diploid Fibroblast

>>> ○ Diameter: 16-18 μm. Volume: 2500 μm<sup>3</sup>

>>> ○ Cells/g × 10<sup>6</sup>: 400 (calculated), 180 (measured)

> ⑤ Flow Cytometry

>> ○ Determines types and quantities of cells in cell suspension by discerning cells with specific antigens through antigen-antibody reactions

>> ○ If the function of sorting desired cells is added, it's called FACS (fluorescence-activated cell sorter)

⑷ Cell Staining

> ① [Cell Toxicity Experiment](https://jb243.github.io/pages/427): XTT assay, WST assay, CCK-8 assay, etc.

> ② [Oil Red O Staining](https://jb243.github.io/pages/447): Evaluation of adipocyte differentiation

> ③ [Alizarin Red S Staining](https://jb243.github.io/pages/447)(alizarin red S staining): Evaluation of osteoblast differentiation

> ④ DCF Staining (Dichlorofluorescein Assay): ROS Evaluation

> ⑤ Nissl bodies (Nissl substance)

>> ○ The ribosomes and rough (granular) endoplasmic reticulum are stained, producing a tigroid (leopard-like) pattern.

>> ○ The dyes used for Nissl staining are basic (cationic) dyes.

> ⑥ Giemsa banding: A technique in which AT-rich heterochromatin stains dark and GC-rich euchromatin stains light; used for karyotype analysis.

<br>

<img width="454" height="356" alt="image" src="https://github.com/user-attachments/assets/e28c1cf1-3035-4cd2-a372-28cd6ee3462b" />

**Figure 2.** A male's Giemsa banding photo

<br>

⑸ DNA Technology

> ① [DNA Recombination](https://jb243.github.io/pages/77#footnote_link_67_50)

> ② [Gene Library](https://jb243.github.io/pages/77#footnote_link_67_51)

> ③ [PCR](https://jb243.github.io/pages/77#footnote_link_67_52) (Polymerase Chain
Reaction)

> ④ [DNA fingerprinting](https://jb243.github.io/pages/77#footnote_link_67_53)

> ⑤ [Hybridization](https://jb243.github.io/pages/77#footnote_link_67_54): Southern blotting, Northern blotting, Western blotting, DNA chip (microarray), ISH (in situ hybridization)

> ⑥ [Gene deletion](https://jb243.github.io/pages/77#footnote_link_67_55): knockout mouse, Cre-lox, siRNA

> ⑦ [Nuclear transfer](https://jb243.github.io/pages/77#footnote_link_67_56): nuclear transfer, transgenic organisms, genetically modified foods

> ⑧ [DNA-protein interaction studies](https://jb243.github.io/pages/77#footnote_link_67_57): genetic (DNA) fingerprinting, EMSA, ChIP

> ⑨ [Protein-protein interaction studies](https://jb243.github.io/pages/77#footnote_link_67_58): two-hybrid system, yeast two-hybrid

> ⑩ [Gene therapy](https://jb243.github.io/pages/77#footnote_link_67_59): CRISPR/Cas9 gene-editing technology, siRNA therapeutics, mRNA drug-delivery systems

⑹ [_in vitro_ Sequencing](https://jb243.github.io/pages/75#footnote_link_67_52)

> ① Sequencing Methods

>> ○ in vitro Cloning

>> ○ Dideoxy Chain Termination Method

>> ○ Dye-Dideoxy Chain Termination Method

>> ○ Pyrosequencing

>> ○ Illumina Solid-Phase Amplification

> ② Sequencing Applications

>> ○ WGS (Whole Genome Sequencing)

>> ○ WES (Whole Exome Sequencing)

>> ○ ChIP-seq

>> ○ scRNA-seq (Single Cell RNA Sequencing)

>> ○ Bisulfite Sequencing

>> ○ Hi-C Sequencing

>> ○ Long Read Sequencing

>> ○ Non-invasive Sequencing

⑺ [Microbiology Experiments](https://jb243.github.io/pages/1487)

<br>

<br>

## **3\. Tissue Experiment**

 ⑴ Tissue Observation

> ① <b>H&amp;E staining</b>

>> ○ Overview

>>> ○  "H" stands for hematoxylin, a basic dye; "E" stands for eosin, an acidic dye.

>>> ○  H&amp;E staining is the standard method in clinical pathology for determining a patient's disease and guiding treatment.

>> ○ <b>Step 1:</b> Fixation

>>> ○ Typically performed with 10% neutral buffered formalin to prevent tissue autolysis and microbial putrefaction.

>> ○ <b>Step 2:</b> Gross section (grossing)

>>> ○ Trimming the tissue to an appropriate size and shape.

>> ○ <b>Step 3:</b> Washing

>> ○ <b>Step 4:</b> Tissue processing

>>> ○ <b>4-1.</b> Dehydration: removing water from the tissue.

>>> ○ <b>4-2.</b> Clearing: replacing the alcohol used for dehydration with xylene.

>>> ○ <b>4-3.</b> Infiltration: permeating the tissue with paraffin.

>> ○ <b>Step 5:</b> Embedding

>>> ○ Forming a paraffin block to enable thin sectioning; an embedding center is used.

>> ○ <b>Step 6:</b> Sectioning

>>> ○ Cutting to a thickness suitable for microscopic observation; a microtome is used.

>> ○ <b>Step 7:</b> H&amp;E staining and mounting

>>> ○ Staining the paraffin sections with H&amp;E and covering with a cover glass for microscopy.

>>> ○ Nuclei: stained purple by hematoxylin.

>>> ○ Cytoplasm: stained red by eosin.

>>> ○ Recently, automated devices such as autostainers are widely used for H&amp;E.

<br>

<img width="950" height="622" alt="image" src="https://github.com/user-attachments/assets/98aac4e3-6efc-49a6-b957-1c45517df659" />

**Figure 3.** H&E Staining

<br>

>> ○ <b>Step 8:</b> [Histopathological Interpretation](https://jb243.github.io/pages/2086#footnote_link_67_50)

> ② Other Tissue Staining Techniques

>> ○ [Immunohistochemistry](https://jb243.github.io/pages/1461#footnote_link_67_52) (IHC) Staining

>> ○ ALP assay (alkaline phosphatase assay)

>>> ○ ALP is an enzyme found primarily in the liver and bone.

>>> ○ In an alkaline environment around pH 10.5, it hydrolyzes hydroxyapatite.

>>> ○ Measured by absorbance at 405 nm.

>> ○ MT staining (Masson's Trichrome staining)

>>> ○ Red: cytoplasm, keratin, muscle fibers, erythrocytes

>>> ○ Black: nuclei

>>> ○ Blue: collagen, mucin, collagen fibers

>> ○ PAS (Periodic acid–Schiff) staining

>>> ○ A special stain used to visualize purple glycogen.

>>> ○ Can also detect other polysaccharides and mucosubstances (e.g., mucin, glycoproteins).

>> ○ Jones' Silver Stain: Staining for basement membrane

>> ○ Sirius Red Staining: Special staining for observing red collagen components

>> ○ Alcian Blue Staining: Staining for mucin

>> ○ pH Map

>> ○ DHE (Dihydroethidium) Staining: Detection of superoxide

>> ○ Picrosirius Red Staining: ECM staining

>> ○ Luxol fast blue: Used in cytopathology and to assess the integrity of cerebral white matter.

>> ○ Herovici staining: Stains collagen deposits.

>> ○ PHH3 staining (phospho-histone H3).

 ⑵ 3D Imaging Acquisition

> ① Intravital Imaging

>> ○ Experimental process

<br>

<img width="640" height="397" alt="image" src="https://github.com/user-attachments/assets/2ad219e6-e1af-47d2-9b69-2e485185ad42" />

**Figure 4.** Intravital Imaging Experimental Process

<br>

>> ○ GSL-1-cy3 is used for intravital imaging of blood vessel walls.

> ② [3D Immunostaining](https://jb243.github.io/pages/1461#footnote_link_67_53)

> ③ [Other 3D Imaging Devices](https://jb243.github.io/pages/1202)

>> ○ [US](https://jb243.github.io/pages/739#footnote_link_67_53): Assesses health status by using the frequency (Doppler) shift between ultrasound emitted by the probe and that reflected from blood.

>> ○ [PET](https://jb243.github.io/pages/2062): A three-dimensional, noninvasive imaging modality that detects pairs of γ rays produced when a positron-emitting radionuclide meets an electron and undergoes annihilation.

>> ○ [MRI](https://jb243.github.io/pages/1842): Uses nuclear magnetic resonance to noninvasively evaluate the magnetic relaxation properties of tissues or samples.

>> ○ [CT](https://jb243.github.io/pages/1050): X-ray–based tomography in which structures that transmit X-rays more readily appear darker; multiple projections around the subject are used to reconstruct a 3D image.

>> ○ [SPECT](https://jb243.github.io/pages/2079): Uses γ-emitting radionuclides for tomographic imaging, analogous in acquisition geometry to X-ray CT.

>> ○ TPEM (two-photon excitation microscopy).

⑶ Tissue Toxicity Tests

> ① Intradermal Reaction

>> ○ Evaluate local irritancy that appears after intradermal injection of the test article.

>> ○ Used when animal-based irritancy tests are not applicable or when the test article is hydrophobic.

> ② Hemolysis Test

>> ○ Assesses the degree of erythrocyte lysis and the release of hemoglobin.

>> ○ 1<sup>st</sup>. Add blood to an EDTA-containing evacuated collection tube and incubate.

>> ○ 2<sup>nd</sup>. After 1 hour of incubation, centrifuge.

>> ○ 3<sup>rd</sup>. Collect the supernatant and measure the extent of hemoglobin release.

>> ○ 4<sup>th</sup>. Hemolysis rate (%) = (Absorbance of test solution − Absorbance of blank) ÷ (Absorbance of positive control − Absorbance of blank) × 100.

> ③ Platelet Aggregation Test

>> ○ <b>Type 1:</b> Platelet count.

>> ○ <b>Type 2:</b> Platelet aggregation.

>> ○ <b>Type 3:</b> Blood cell adhesion measurement: fewer adherent cells indicate higher blood compatibility.

> ④ Immunological Assays

>> ○ 1<sup>st</sup>. Peripheral blood mononuclear cells (PBMCs) encounter foreign material, trigger an inflammatory response, and produce various cytokines.

>> ○ 2<sup>nd</sup>. Quantify production by reverse-transcription PCR or enzyme-linked immunosorbent assay (ELISA).

> ⑤ Plasma Protein Coagulation Tests

>> ○ Evaluate the behavior of plasma proteins on material surfaces.

>> ○ Plasma proteins include albumin, globulins, fibrinogen, immunoglobulins, etc.

>> ○ Types of plasma protein coagulation tests:

>>> ○ Partial thromboplastin time (PTT)

>>> ○ Prothrombin time (PT)

>>> ○ Thrombin time (TT)

>>> ○ Fibrinogen

>>> ○ Fibrinogen and fibrin degradation products (FDP)

>>> ○ Specific coagulation factor assays

>>> ○ FPA, D-dimer, F<sub>1+2</sub>, TAT

>>> ○ Lee–White method

>>> ○ Imai–Nose method

> ⑥ [Hematology Tests](https://jb243.github.io/pages/1473)

⑷ [_in situ_ Sequencing](https://jb243.github.io/pages/75#footnote_link_67_52)

> ① ISS ( _in situ_ sequencing)

> ② Spatial Transcriptomics

<br>

<br>

## **4\. Animal Experiments**

 ⑴ Overview: Corresponds to preclinical experiments

 ⑵ General Process of Animal Experiments

> ① [Observation of Experimental Animals](https://jb243.github.io/pages/1936)

> ② [Calibration, Administration, Blood Collection](https://jb243.github.io/pages/1937)

> ③ [Anesthesia Methods, Euthanasia, Autopsy](https://jb243.github.io/pages/1938)

> ④ [Toxicity Testing](https://jb243.github.io/pages/1939)

> ⑤ [Tumor Models](https://jb243.github.io/pages/2137)

> ⑥ Regulations on Animal Experiments: Animal testing is generally prohibited for cosmetics.

 ⑶ Resources

> ① The Jackson Laboratory ([ref1](http://www.informatics.jax.org/mgihome/other/mgi_people.shtml), [ref2](http://tumour.informatics.jax.org/mtbwi/index.do), [ref3](http://phenome.jax.org/)): Provides useful resources related to animal experiments

⑷ [Pharmacology](https://jb243.github.io/pages/2197)

> ① Study of biochemical reactions of body related to drug and drug administration

> ② Divided into Pharmacodynamics (PD) and Pharmacokinetics (PK)

<br>

<br>

## **5\. Clinical Trial

 ⑴ Overview: Involves humans. Typically performed sequentially: cell experiments → animal experiments → clinical trials.

> ① Drug Development Phases

>> ○ Drug Discovery: 3 ~ 5 years

>> ○ Preclinical: 1 ~ 2 years

>> ○ Clinical Trials: 6 ~ 7 years

>> ○ FDA Approval: 1 ~ 2 years

> ② Approximately 50 ~ 60 new drugs are approved by the FDA annually.

> ③ Increasing costs and a failure rate of around 90%.

> ④ Most failures are due to lack of therapeutic effect.

>> ○ Efforts are made to prevent this by focusing on efficacy and dose finding even in Phase 1.

>> ○ Phase 0 studies are introduced to administer drugs to humans more quickly.

>> ○ PET imaging can also be used as a strategy.

 ⑵ **Phase 1 Clinical Trials**: Exploratory clinical trials

> ① Involving 20 ~ 80 participants

> ② **Type 1:** If the purpose is safety assessment, healthy volunteers are used.

> ③ **Type 2:** Anti-cancer drugs: Tested on a small number of terminal cancer patients.

> ④ Objectives

>> ○ Pharmacokinetics: Theory on ADME

>> ○ Interactions

>> ○ Safety (dose dependent)

>> ○ Maximum Tolerated Dose (MTD), tolerable dose range, dose-response studies

>> ○ PK / PD studies

> ⑤ Methods

>> ○ Dose-response curve: NOAEL, NOEL, MED (Min Effective Dose), MABEL

>> ○ Single dose rising, multiple dose rising

>> ○ Drug-drug interaction

 ⑶ **Phase 2 Clinical Trials**: More participants are involved, exploratory clinical trials

> ① Involving 100 ~ 200 participants

> ② Early Phase 2 Clinical Trials (IIa): Assessing efficacy

> ③ Late Phase 2 Clinical Trials (IIb): Dose finding

 ⑷ **Phase 3 Clinical Trials**: Final stage of clinical trials for obtaining market approval. Confirmatory clinical trials

> ① Conducted on a large scale for statistical confirmation

> ② Objectives: Confirming safety and therapeutic effectiveness

> ③ Generally takes around 5 ~ 6 years until market approval (long-term)

 ⑸ **Phase 4 Clinical Trials**: Long-term assessment of new drug's efficacy and safety after market use

> ① Post-marketing surveillance

<br>

---

_Input**:** 2019.11.30 10:43_

_Last Update**:** 2022.11.07 22:51_



